Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Vaccinia
×
Sorafenib
×
Clear all
Filters
3
NCT02562755
2020-12-16
PHOCUS
SillaJen, Inc.
Phase 3
Completed
459 enrolled
12 charts